Farmacogenomica e chemioterapia: Attuali conoscenze

Ida Paris; Gian Carlo Antonini Cappellini; Paola Malaguti; Maria Bassanelli; Paolo Marchetti

doi:10.1701/508.6078

Farmacogenomica e chemioterapia: Attuali conoscenze

Translated title of the contribution: Pharmacogenomics and chemotherapy

Ida Paris, Gian Carlo Antonini Cappellini, Paola Malaguti, Maria Bassanelli, Paolo Marchetti

Istituto Dermopatico dell'Immacolata , IDI

Research output: Contribution to journal › Article

Abstract

Genetic factors could alter drug metabolism and activity and could predict drug toxicity and/or efficacy. Several chemotherapy agents are administered in different schedules for the treatment of different cancer histotypes. The most used drug in the treatment of gastro-intestinal, head and neck and breast neoplasms is the 5-fluorouracil (5-FU). Capecitabine is a prodrug of 5-FU. Cisplatin based chemotherapy is administered in the treatment of lung, genitourinary tract, head and neck, occult neoplasms, mesothelioma and melanoma. Taxanes are used in lung, breast, head and neck, genitourinary tract neoplasms and sarcomas. Determination of polymorphisms in metabolizing enzymes before the administration of chemotherapy could offer new strategies for optimizing the treatment of individual patients.

Translated title of the contribution	Pharmacogenomics and chemotherapy
Original language	Italian
Pages (from-to)	277-282
Number of pages	6
Journal	Recenti Progressi in Medicina
Volume	101
Issue number	7-8
DOIs	https://doi.org/10.1701/508.6078
Publication status	Published - Jul 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1701/508.6078

Fingerprint Dive into the research topics of 'Pharmacogenomics and chemotherapy: Attuali conoscenze'. Together they form a unique fingerprint.

Cite this

Paris, I., Cappellini, G. C. A., Malaguti, P., Bassanelli, M., & Marchetti, P. (2010). Farmacogenomica e chemioterapia: Attuali conoscenze. Recenti Progressi in Medicina, 101(7-8), 277-282. https://doi.org/10.1701/508.6078

@article{d8818e96c95a40ed96143afb3fc0a9a2,

title = "Farmacogenomica e chemioterapia: Attuali conoscenze",

abstract = "Genetic factors could alter drug metabolism and activity and could predict drug toxicity and/or efficacy. Several chemotherapy agents are administered in different schedules for the treatment of different cancer histotypes. The most used drug in the treatment of gastro-intestinal, head and neck and breast neoplasms is the 5-fluorouracil (5-FU). Capecitabine is a prodrug of 5-FU. Cisplatin based chemotherapy is administered in the treatment of lung, genitourinary tract, head and neck, occult neoplasms, mesothelioma and melanoma. Taxanes are used in lung, breast, head and neck, genitourinary tract neoplasms and sarcomas. Determination of polymorphisms in metabolizing enzymes before the administration of chemotherapy could offer new strategies for optimizing the treatment of individual patients.",

keywords = "5-fluorouracil toxicity, Dihydropyrimidine dehydrogenase, ERCC1 expression in non small cell lung cancer, Irinotecan toxicity, MTHFR, Taxanes and drug transporters, Thymidylate synthase gene polymorphisms, UGT1A1",

author = "Ida Paris and Cappellini, {Gian Carlo Antonini} and Paola Malaguti and Maria Bassanelli and Paolo Marchetti",

year = "2010",

month = jul,

doi = "10.1701/508.6078",

language = "Italian",

volume = "101",

pages = "277--282",

journal = "Recenti Progressi in Medicina",

issn = "0034-1193",

publisher = "Il Pensiero Scientifico Editore s.r.l.",

number = "7-8",

}

TY - JOUR

T1 - Farmacogenomica e chemioterapia

T2 - Attuali conoscenze

AU - Paris, Ida

AU - Cappellini, Gian Carlo Antonini

AU - Malaguti, Paola

AU - Bassanelli, Maria

AU - Marchetti, Paolo

PY - 2010/7

Y1 - 2010/7

N2 - Genetic factors could alter drug metabolism and activity and could predict drug toxicity and/or efficacy. Several chemotherapy agents are administered in different schedules for the treatment of different cancer histotypes. The most used drug in the treatment of gastro-intestinal, head and neck and breast neoplasms is the 5-fluorouracil (5-FU). Capecitabine is a prodrug of 5-FU. Cisplatin based chemotherapy is administered in the treatment of lung, genitourinary tract, head and neck, occult neoplasms, mesothelioma and melanoma. Taxanes are used in lung, breast, head and neck, genitourinary tract neoplasms and sarcomas. Determination of polymorphisms in metabolizing enzymes before the administration of chemotherapy could offer new strategies for optimizing the treatment of individual patients.

AB - Genetic factors could alter drug metabolism and activity and could predict drug toxicity and/or efficacy. Several chemotherapy agents are administered in different schedules for the treatment of different cancer histotypes. The most used drug in the treatment of gastro-intestinal, head and neck and breast neoplasms is the 5-fluorouracil (5-FU). Capecitabine is a prodrug of 5-FU. Cisplatin based chemotherapy is administered in the treatment of lung, genitourinary tract, head and neck, occult neoplasms, mesothelioma and melanoma. Taxanes are used in lung, breast, head and neck, genitourinary tract neoplasms and sarcomas. Determination of polymorphisms in metabolizing enzymes before the administration of chemotherapy could offer new strategies for optimizing the treatment of individual patients.

KW - 5-fluorouracil toxicity

KW - Dihydropyrimidine dehydrogenase

KW - ERCC1 expression in non small cell lung cancer

KW - Irinotecan toxicity

KW - MTHFR

KW - Taxanes and drug transporters

KW - Thymidylate synthase gene polymorphisms

KW - UGT1A1

UR - http://www.scopus.com/inward/record.url?scp=77957332196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957332196&partnerID=8YFLogxK

U2 - 10.1701/508.6078

DO - 10.1701/508.6078

M3 - Articolo

C2 - 20842953

AN - SCOPUS:77957332196

VL - 101

SP - 277

EP - 282

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 7-8

ER -